Cirrhosis Therapeutics Clinical Trials Review H1 2015 Market Research Report
DALLAS, January 26, 2015 /PRNewswire/ --
RnRMarketResearch.com adds "Cirrhosis Global Clinical Trials Review, H1, 2015" to its store. The report provides elemental information and data relating to the clinical trials on Cirrhosis.
The report "Cirrhosis Global Clinical Trials Review, H1, 2015" provides elemental information and data relating to the clinical trials on Cirrhosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. Cirrhosis is a complication of liver disease which involves loss of liver cells and permanent scarring of the liver. The scar tissue blocks the flow of blood through the liver and slows the processing of nutrients, hormones, drugs, and naturally produced toxins. Cirrhosis is most commonly caused by alcoholism, hepatitis B and hepatitis C, and fatty liver disease. Transplantation of the liver is becoming an important option for treating patients with advanced cirrhosis. Globally 57% of cirrhosis is attributable to either hepatitis B or hepatitis C.
The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cirrhosis. Companies discussed in this Cirrhosis Global Clinical Trials Review H1 2015 report include Merck & Co., Inc., Novartis AG, Genextra S.p.a., GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., Zambon Company S.p.A., Sanofi, Otsuka Holdings Co., Ltd., AbbVie Inc., Pfizer Inc.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Order a Purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=268948 . (This is a premium report priced at US$2500 for a single user License.)
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons To Buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
List of Tables provided in this H1 2015 review report of Cirrhosis Therapeutics:
Cirrhosis Therapeutics, Global, Clinical Trials by Region, 2015
Cirrhosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015
Cirrhosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015
Cirrhosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015
Cirrhosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015
Cirrhosis Therapeutics Clinical Trials, North America, Top Countries, 2015
Cirrhosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015
Cirrhosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015
Proportion of Cirrhosis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015
Cirrhosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015
Cirrhosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015
Proportion of Cirrhosis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015
Cirrhosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015
Cirrhosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015
Cirrhosis Therapeutics, Global, Clinical Trials by Phase, 2015
Cirrhosis Therapeutics, Global, Clinical Trials In Progress by Phase 2015
Cirrhosis Therapeutics, Global, Clinical Trials by Trial Status, 2015
Cirrhosis Therapeutics Clinical Trials, Global, by End Point Status, 2015
Cirrhosis Therapeutics, Global, Suspended Clinical Trials, 2015
Cirrhosis Therapeutics, Global, Withdrawn Clinical Trials, 2015
Cirrhosis Therapeutics, Global, Terminated Clinical Trials, 2015
Cirrhosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
Cirrhosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015
Cirrhosis Therapeutics Clinical Trials, Global, Key Sponsors, 2015
Cirrhosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015
Cirrhosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Genextra S.p.a., 2015
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Zambon Company S.p.A., 2015
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2015
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Clinic de Barcelona, 2015
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2015
Explore more reports on Clinical Trial industry at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/clinical-trial .
About Us:
RnRMarketResearch.com is a digital library of 500,000+ syndicated market research reports and in-depth studies of 5000+ micro markets. We provide reports by 100+ publishers on a range of categories and industries.
Contact:
Ritesh Tiwari
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252
Tel: +1-888-391-5441
Connect with Us:
G+ / Google Plus: https://plus.google.com/104156468549256253075/posts
Twitter: https://twitter.com/RnRMR
Facebook: https://www.facebook.com/pages/RnR-Market-Research/413488545356345
RSS / Feeds: http://www.rnrmarketresearch.com/feed
SOURCE RnR Market Research
Share this article